Hatteras Venture Partners

Hatteras Venture Partners is a venture capital and private equity firm specializing in buyouts, pre-seed, seed/startup, early stage, emerging growth, growth capital, and mid venture stages. The firm is an SBIC. It typically invests in life sciences and healthcare companies with a focus on biopharmaceuticals, medical devices, medical device research and development, diagnostics, healthcare IT and health related technologies, and services opportunities in human medicine and health. The firm primarily invests in companies located in the research-driven and capitally-underserved regions of Mid Atlantic such as North Carolina and the Southeastern United States. It seeks to invest between $0.5 million and $4 million initially; and between $5 million and $20 million in total.

TypeInvestor
HQDurham, US
Founded2000
Websitehatterasvp.com
Hatteras Venture Partners was founded in 2000 and is headquartered in Durham, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Hatteras Venture Partners

Christy Shaffer

Christy Shaffer

Partner
Myla Lai-Goldman

Myla Lai-Goldman

Venture Partner
Jeff Terrell

Jeff Terrell

Associate
Ben Scruggs

Ben Scruggs

Analyst
Michael Dial

Michael Dial

Principal
Show more

Hatteras Venture Partners Office Locations

Hatteras Venture Partners has an office in Durham
Durham, US (HQ)
280 S Mangum St #350
Show all (1)

Hatteras Venture Partners Online and Social Media Presence

Embed Graph

Hatteras Venture Partners Blogs

Alkermes to Acquire Rodin Therapeutics

— Acquisition to Expand Alkermes’ Presence in CNS to a Wide Range of Neurodegenerative Diseases Through Epigenetic Control of Synaptogenesis — DUBLIN, Ireland and BOSTON, Mass., Nov. 18, 2019 — Alkermes plc (Nasdaq: ALKS) and Rodin Therapeutics, Inc. (Rodin) today announced that they have entered in…

Sarepta pays StrideBio $48M for preclinical gene therapies

by Nick Paul Taylor Nov 15, 2019 8:15am Sarepta Therapeutics is set to pay $48 million upfront to work with StrideBio on gene therapies. The deal gives Sarepta exclusive licenses to four CNS targets, plus an option to pay a further $42.5 million to add another four targets to the deal. In return for…

NextGen Healthcare Announces Agreement to Acquire Medfusion, Inc.

Leading Patient Experience Platform Advances Company’s Market Position November 13, 2019 08:00 AM Eastern Standard Time IRVINE, Calif.–(BUSINESS WIRE)–NextGen Healthcare, Inc. (NASDAQ:NXGN) (“NextGen Healthcare” or “the Company”), a leading provider of ambulatory-focused technology solutions, today …

Clearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery

ALPHARETTA, Ga., Oct. 30, 2019 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that REGENXBIO Inc. (Nasdaq: R…

Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China

— Multi-product collaboration will address pathogens for which the World Health Organization (WHO) has declared there is a “critical need” for new drugs due to carbapenem-resistance in Acinetobacter, Pseudomonas aeruginosa, and Enterobacteriaceae (CRE) — Qpex grants license to its current product po…

A twisty career path to improve care for smokers

Jennifer Huber October 11, 2019 When Jason Melehani, MD, PhD, grew up in a small town in the Sierra Nevada foothills, he didn’t know any scientists or doctors. That all changed when he went to college at the University of California, Los Angeles and discovered the world of research. Now, Melehani is…
Show more

Hatteras Venture Partners Frequently Asked Questions

  • When was Hatteras Venture Partners founded?

    Hatteras Venture Partners was founded in 2000.

  • Who are Hatteras Venture Partners key executives?

    Hatteras Venture Partners's key executives are Christy Shaffer, Myla Lai-Goldman and Jeff Terrell.

  • Where is Hatteras Venture Partners headquarters?

    Hatteras Venture Partners headquarters is located at 280 S Mangum St #350, Durham.

  • Where are Hatteras Venture Partners offices?

    Hatteras Venture Partners has an office in Durham.

  • How many offices does Hatteras Venture Partners have?

    Hatteras Venture Partners has 1 office.